Senior Director, Medical Affairs, South Europe at Acadia Pharmaceuticals

Italy

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Rare DiseasesIndustries

Requirements

Advanced science or clinical degree (e.g. MD, Pharm.D., PhD)
10+ years Medical Science Liaison, Medical Advisor/Manager and at least 3 years of experience as Medical Director, preferable in a start-up environment
Knowledge of local country regulations, guidelines, codes of practices
Rare disease experience or prior experience in hepatology and/or gastroenterology preferred; Launch experience preferred
Regulatory and market access experience highly desirable
Ability to maintain scientific credibility while being commercially supportive, and to understand and effectively communicate scientific results and effectively respond to inquiries

Responsibilities

Creates and timely implements South Europe medical strategy and tactics in line with international/global medical strategy and cluster priorities
Closely working with the Cluster Team, leads planning and execution of South Europe and subregional medical activities, including but not limited to Advisory Boards, Satellite and Standalone symposia, Workshops, etc
Leads the execution of EAP programs and ensures real world data is provided in a timely manner both internally and to Italian/Spanish/Portuguese authorities
Identifies, can gain access to, and develops professional relationships with thought leaders and other healthcare professionals, active and potential study investigators, and professional organizations within South Europe
Supports South Europe market access activities to create strong health economic dossiers, hearing presentation that will be tested extensively with medical experts and national leaders who may also have to represent it to reimbursement authorities
Supports research initiatives across development and provides support to clinical site investigators; Supports company-sponsored research, investigator-initiated research, and publications
Utilizes scientific resources to deliver impactful presentations to varying audiences and in a variety of different settings including patient advocacy groups and payors
Supports South Europe commercial activities including (but not limited to) symposia and all other launch activities
Is responsible to comply with all obligations defined by local laws and regulations including medical approval and application of relevant legislation and regulation, in spirit as well as by the letter, and in particular, in the country’s activities (validation of material (promotional or not), certification of sales force, etc.)
Ensures appropriate training of the affiliate to maintain levels of scientific and medical up-to-date according to state of medico-scientific knowledge
Gets involved in South European PV activities with Vendor if necessary, as well as in Medical Information activities
Stays abreast of emerging scientific literature and clinical data
Forecasts and manages the medical budget
Completes other responsibilities in a timely manner, as assigned by the line manager and Regional GM

Skills

Medical Affairs

Thought Leader Engagement

Medical Strategy

Advisory Boards

Symposia

EAP Programs

Real World Data

Market Access

Health Economics

Pharmacovigilance

Regulatory Affairs

Compliance

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free